Multiple Sclerosis Clinical Trials in Philadelphia

Showing 541-560 of 741 trials

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

NCT00875563

The Zenith(R) Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.

Abdominal Aortic AneurysmsAorto-iliac AneurysmsJuxtarenal Aneurysms

Cook Group Incorporated42 participantsStarted Jan 2005

San Francisco, California, United States • Gainesville, Florida, United States • Indianapolis, Indiana, United States +11 more locations

COMPLETEDPhase 2< 1 mile

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

NCT00524303

This study will examine safety and efficacy of Lapatinib in combination with a standard neoadjuvant chemotherapy including 5FU, Epirubicin, Cyclophosphamide and Paclitaxel. Tumor tissue will be obtained at 3 timepoints (optional 4th) to evaluate tumor response to treatment.

Neoplasms, Breast

GlaxoSmithKline100 participantsStarted Aug 2007

Fountain Valley, California, United States • Los Angeles, California, United States • Denver, Colorado, United States +20 more locations

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

Multiple Sclerosis Trials in Other Cities

Mental Health Services for Toddlers in Foster Care

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer

EPO906 Therapy in Patients With Advanced Breast Cancer

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.

A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors

A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors

A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)

Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.

Efficacy and Safety of GTR in Comparison to Copaxone®

Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Other Conditions in Philadelphia